# GADD45G

## Overview
GADD45G, or growth arrest and DNA damage inducible gamma, is a gene that encodes a protein belonging to the GADD45 family, which is involved in cellular stress responses, particularly in growth suppression and apoptosis. The protein encoded by GADD45G is primarily localized in the cell nucleus and plays a critical role in maintaining genomic stability by participating in DNA repair and cell cycle regulation. It interacts with key proteins such as proliferating cell nuclear antigen (PCNA) and the cyclin-dependent kinase inhibitor p21, which are essential for cell cycle arrest and DNA repair processes (Azam2001Interaction). GADD45G is also involved in activating stress-responsive kinase pathways, such as the p38/JNK pathways, which are crucial for cellular responses to stress (Azam2001Interaction). As a tumor suppressor gene, GADD45G is frequently downregulated in various cancers, often through hypermethylation, which contributes to tumorigenesis by allowing cells to evade apoptosis (Zerbini2005GADD45). Additionally, GADD45G has been implicated in neuropsychiatric disorders, where its expression is associated with DNA demethylation processes and the regulation of depressive-like behaviors (Huang2024Advances).

## Structure
The GADD45G protein structure is characterized by a compact arrangement featuring a five-strand β-sheet surrounded by five α-helices. The β-strands are organized in the sequence B1-B4-B2-B3-B5, with B1-B4-B2 being anti-parallel and B2-B3-B5 being parallel. Helices H1, H4, and H5 are positioned below the β-sheet, with H1 and H5 oriented perpendicularly to the β-strands. Above the β-sheet, helices H2 and H3 are parallel to each other and approximately parallel or antiparallel to the β-strands. The most stable regions of the protein include the five-strand β-sheet and helices H2, H3, and H5 (Zhang2011Crystal).

The quaternary structure of GADD45G involves a parallel dimer formed by the interleaving of four α-helices, specifically two H2's and two H3's. This dimerization is crucial for the protein's function in apoptosis and growth inhibition, as it facilitates interactions with other proteins involved in cell cycle regulation and DNA repair. The dimer interface is predominantly hydrophobic, with significant contributions from the side chain of Leu80 on H3, which penetrates into the cavity between H2 and H3 of the neighboring monomer (Zhang2011Crystal).

## Function
The GADD45G gene encodes a protein that plays a crucial role in cellular stress responses, particularly in growth suppression and apoptosis. This protein is part of the MyD118/GADD45 family, which includes GADD45α, β, and γ, and is primarily localized within the cell nucleus (Azam2001Interaction). GADD45G interacts with proliferating cell nuclear antigen (PCNA) and the cyclin-dependent kinase inhibitor p21, which are important for cell cycle regulation and DNA repair. These interactions are essential for impeding the function of PCNA in negative growth control, thereby maintaining normal cellular homeostasis (Azam2001Interaction).

The protein is involved in activating the stress-responsive MTK1/MEKK4, an upstream activator of the p38/JNK kinase pathways, which are critical for stress response signaling (Azam2001Interaction). GADD45G's interaction with PCNA and p21 suggests its role in cell cycle arrest and DNA repair, contributing to the regulation of cell cycle progression, growth arrest, and apoptosis (Azam2001Interaction). These functions are vital for preventing the propagation of damaged DNA, thus playing a significant role in tumor suppression and maintaining genomic stability in healthy human cells (Azam2001Interaction).

## Clinical Significance
GADD45G is frequently implicated in various cancers due to its role as a tumor suppressor gene. Its expression is often downregulated in cancer cells through hypermethylation, a reversible epigenetic modification. This downregulation is observed in cancers such as breast, ovarian, liver, anaplastic thyroid cancer, and hepatocellular carcinomas, where GADD45G is silenced, allowing cancer cells to evade apoptosis and continue proliferating (Zerbini2005GADD45). The repression of GADD45G, either through methylation or NF-kB activation, is a critical step in oncogenesis, affecting DNA damage response and cell survival (Zerbini2005GADD45).

In neuropsychiatric disorders, GADD45G is involved in the regulation of DNA demethylation processes. Its expression is decreased in models of depression, such as the Flinder Sensitive Line genetic rat model and the Unpredictable Chronic Mild Stress model, which is associated with depressive-like behaviors and cognitive impairments. Treatments like electroconvulsive therapy and metformin have been shown to upregulate GADD45G expression, suggesting its potential role in alleviating depressive symptoms (Huang2024Advances). These findings highlight the significance of GADD45G in both cancer and neuropsychiatric disorders, emphasizing its potential as a therapeutic target.

## Interactions
GADD45G, a member of the GADD45 protein family, is involved in various protein interactions that influence cellular processes such as DNA repair and apoptosis. GADD45G interacts with proliferating cell nuclear antigen (PCNA), a key player in DNA replication and repair. This interaction is significant as it suggests a role for GADD45G in modulating PCNA's function, potentially affecting DNA synthesis and repair processes (Smith1994Interaction). 

GADD45G also interacts with MAGEH1, a protein involved in apoptosis. This interaction has been confirmed through co-immunoprecipitation assays and is implicated in the regulation of renal tubular cell apoptosis, particularly in response to nephrotoxic injury (Shin2021MAGEH1). 

Additionally, GADD45G is known to bind to the kinase domain of MKK7, although with lower affinity compared to other GADD45 family members. This interaction is part of the protein's involvement in stress response pathways, such as the MAPK pathway, which influences apoptosis and cell growth (Smaldone2021Members). These interactions highlight GADD45G's role in maintaining genomic stability and regulating cell cycle processes.


## References


[1. (Azam2001Interaction) Naiyer Azam, Mariappan Vairapandi, Wei Zhang, Barbara Hoffman, and Dan A. Liebermann. Interaction of cr6 (gadd45γ) with proliferating cell nuclear antigen impedes negative growth control. Journal of Biological Chemistry, 276(4):2766–2774, January 2001. URL: http://dx.doi.org/10.1074/jbc.m005626200, doi:10.1074/jbc.m005626200. This article has 71 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m005626200)

[2. (Shin2021MAGEH1) Gyu-Tae Shin, Ji Eun Park, and Min-Jeong Lee. Mageh1 interacts with gadd45g and induces renal tubular cell apoptosis. PLOS ONE, 16(11):e0260135, November 2021. URL: http://dx.doi.org/10.1371/journal.pone.0260135, doi:10.1371/journal.pone.0260135. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0260135)

[3. (Smaldone2021Members) Giovanni Smaldone, Daniela Caruso, Annamaria Sandomenico, Emanuela Iaccarino, Annalia Focà, Alessia Ruggiero, Menotti Ruvo, and Luigi Vitagliano. Members of the gadd45 protein family show distinct propensities to form toxic amyloid-like aggregates in physiological conditions. International Journal of Molecular Sciences, 22(19):10700, October 2021. URL: http://dx.doi.org/10.3390/ijms221910700, doi:10.3390/ijms221910700. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms221910700)

[4. (Smith1994Interaction) Martin L. Smith, I.-Tsuen Chen, Qimin Zhan, Insoo Bae, Chaw-Yuan Chen, Tona M. Gilmer, Michael B Kastan, Patrick M. O’Connor, and Albert J. Fornace. Interaction of the p53-regulated protein gadd45 with proliferating cell nuclear antigen. Science, 266(5189):1376–1380, November 1994. URL: http://dx.doi.org/10.1126/science.7973727, doi:10.1126/science.7973727. This article has 686 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.7973727)

[5. (Zerbini2005GADD45) Luiz F. Zerbini and Towia A. Libermann. Gadd45 deregulation in cancer: frequently methylated tumor suppressors and potential therapeutic targets. Clinical Cancer Research, 11(18):6409–6413, September 2005. URL: http://dx.doi.org/10.1158/1078-0432.CCR-05-1475, doi:10.1158/1078-0432.ccr-05-1475. This article has 59 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/1078-0432.CCR-05-1475)

[6. (Huang2024Advances) Mengbing Huang, Ji Wang, Wei Liu, and Hongyan Zhou. Advances in the role of the gadd45 family in neurodevelopmental, neurodegenerative, and neuropsychiatric disorders. Frontiers in Neuroscience, January 2024. URL: http://dx.doi.org/10.3389/fnins.2024.1349409, doi:10.3389/fnins.2024.1349409. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnins.2024.1349409)

[7. (Zhang2011Crystal) Wenzheng Zhang, Sheng Fu, Xuefeng Liu, Xuelian Zhao, Wenchi Zhang, Wei Peng, Congying Wu, Yuanyuan Li, Xuemei Li, Mark Bartlam, Zong-Hao Zeng, Qimin Zhan, and Zihe Rao. Crystal structure of human gadd45 reveals an active dimer. Protein &amp; Cell, 2(10):814–826, October 2011. URL: http://dx.doi.org/10.1007/s13238-011-1090-6, doi:10.1007/s13238-011-1090-6. This article has 4 citations.](https://doi.org/10.1007/s13238-011-1090-6)